NCT03009760View on ClinicalTrials.gov

To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

CJ-12420 50mg(HP-)

CJ-12420 50mg in H. pylori negative subject

DRUG

CJ-12420 100mg(HP-)

CJ-12420 100mg in H. pylori negative subject

DRUG

CJ-12420 50mg(HP+)

CJ-12420 50mg in H. pylori positive subject

DRUG

CJ-12420 100mg(HP+)

CJ-12420 100mg in H. pylori positive subject

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

HK inno.N Corporation

INDUSTRY

NCT03009760 - To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration | Biotech Hunter | Biotech Hunter